Home / Workshop Program

Workshop Program

The event will operate on Queensland time / AEST / UTC+10h / GMT+10h

This program is subject to change as we will be adding more presentations and setting the workshop hours.

 

27th of March 2020
Time Title & Speaker Duration
11:30 – Registration
 		 –
12:45 – 13:00 Welcome and Introduction
President, The Australasian Immunohistochemistry Society		 15min
13:00 – 13:25 RCPA-QAP-external quality assessment update
Julia Pagliuso, The Royal College of Pathologists of Australasia-Quality Assurance Programs (RCPA-QAP) – St Leonards NSW, Australia		 25min
13:30 – 13:55 Nordi QC-external quality assessment update
Søren Nielsen, Nordi QC- Institute of Pathology – Aalborg University Hospital, Denmark		 25min
14:00 – 14:25 Medical laboratory accreditation: news and perspectives
Gillian Treloar, NATA (National Association of Testing Authorities, Australia) – Melbourne, VIC, Australia		 25min
14:30 – 15:00 Coffee break
 		 30min
15:00 – 15:25 Technical test approach: the pre-analytical phase
Bron Christiansen, The Royal Children's Hospital – Parkville, VIC, Australia		 25min
15:30 – 15:55 Technical test approach: the analytical phase
Nathan Acott, PathWest Laboratory Medicine – Nedlands, WA, Australia		 25min
16:00 – 16:25 Technical test approach: the post- analytical phase
Hazel Chambers-Smith, The Royal Children's Hospital – Parkville, VIC, Australia		 25min
16:30 – 17:00 RCPA QAP: technical mock assessment
David Gan, Princess Alexandra Hospital – Brisbane, QLD, Australia
RCPA-QAP Team – St Leonards, NSW, Australia		 30min
18:30 – 20:30 Cocktail Party
 		 2hrs
 

28th of March 2020
Time Title & Speaker Duration
7:30 – 8:45 Roche Diagnostics Australia – PD-L1 Masterclass, discussing the PD-L1 landscape and testing within this space.
Dr. Michael Walsh, Sullivan Nicolaides Pathology, Brisbane, Australia		 75min
9:00 – 9:25 The tissue tool box: the journey from antibody to IHC assay
Søren Nielsen, Nordi QC- Institute of Pathology – Aalborg University Hospital, Denmark		 25min
9:30 – 9:55 Cytokeratins in common practice: antibody selection, protocols and controls
Yvette Beaber, Monash Medical Centre, Victoria, Australia		 25min
10:00 – 10:30 Coffee Break
 		 30min
The immunohistochemistry of the unknown primary cancer: approach, panels and NordiQC data
Mogens Vyberg, University of Copenhagen and NordiQC, Denmark		 25min
11:00 – 11:25 Is there a role for immunohistochemistry in the diagnosis of skin
adnexal tumors
Thomas Brenn, Cumming School of Medicine, University of Calgary – Calgary, Canada		 25min
11:30 – 11:55 Update on the use of immunohistochemistry for the diagnosis of
melanocytic tumors
Thomas Brenn, Cumming School of Medicine, University of Calgary – Calgary, Canada		 25min
12:00 – 12:25 Breast markers review: An RCPA-QAP update
Zenobia Haffajee, The Royal College of Pathologists of Australasia-Quality Assurance Programs (RCPA-QAP) –
St Leonards NSW, Australia		 25min
12:30 – 13:00 Lunch
 		 30min
13:00 – 13:55 PDL-1 immunohistochemistry: NordiQC companion module
Søren Nielsen, Nordi QC- Institute of Pathology – Aalborg University Hospital, Denmark		 25min
14:00 – 14:25 The role of immunohistochemistry in gastrointestinal cancer
classification: approach, panels and NordiQC data
Mogens Vyberg, University of Copenhagen and NordiQC, Denmark		 25min
14:30 – 14:55 Molecular biomarkers in endometrial hyperplasia
Emiel Janssen, Stavanger University Hospital – Stavanger, Norway		 25min
15:00 – 15:30 Coffee Break
 		 30min
15:30 – 15:55 Kappa and Lambda light chain assessment: Fit-for-purpose assay development
Eric Burks, Boston University Medical Center Mallory Institute of Pathology
Boston, United States of America		 25min
16:00 – 16:25 Multiplex IHC as a means to aide in the assessment of minimal residual disease (MRD) for plasma cell neoplasms
Eric Burks, Boston University Medical Center Mallory Institute of Pathology
Boston, United States of America		 25min
16:30 – 17:00 Open Forum: bring your problem cases and/or ask questions to:
Nordi-QC, RCPA QAP, NATA. 		30min
19:30 – Drinks and Gala Dinner
 		 –
 

29th of March 2020
Time Title & Speaker Duration
8:20 Gold Sponsors Morning Scientific Session
 		 –
9:00 – 9:25 The role of immunohistochemistry in vascular anomalies of childhood
Jane Dahlstrom, ACT Pathology and Australian National University Medical School – Canberra, ACT, Australia		 25min
9:30 – 9:55 Diagnostic challenges in vascular skin tumours
Thomas Brenn, Cumming School of Medicine, University of Calgary – Calgary, Canada		 25min
10:00 – 10:25 Immunohistochemistry on brain biopsy
Beena Kumar, Monash Medical Centre – Melbourne, VIC, Australia		 25min
10:30 – 11:00 Coffee Break
 		 30min
11:00 – 11:25 The role of immunohistochemistry in the diagnosis of paediatric brain tumours
Hazel Chambers-Smith, The Royal Children's Hospital – Parkville, VIC, Australia		 25min
Markers for classification of lung cancer
Mogens Vyberg, University of Copenhagen and NordiQC, Denmark		 25min
12:00 – 12:25 IHC and molecular diagnostics in non-small cell lung carcinoma
Emiel Janssen, Stavanger University Hospital – Stavanger, Norway		 25min
 

Last update on: 2020/02/25 18:10:08 UTC/GMT time.